4//SEC Filing
Androski Lindsay 4
Accession 0001447028-25-000072
CIK 0001447028other
Filed
Mar 19, 8:00 PM ET
Accepted
Mar 20, 4:08 PM ET
Size
6.0 KB
Accession
0001447028-25-000072
Insider Transaction Report
Form 4
Androski Lindsay
DirectorPresident and CEO
Transactions
- Award
Stock Option (Right to Buy)
2025-03-18+310,422→ 310,422 totalExercise: $3.20Exp: 2035-03-18→ Common Shares (310,422 underlying)
Footnotes (2)
- [F1]Reflects the closing price of the Company's common shares on the Nasdaq Stock Market on the date of the grant.
- [F2]This option vests over a four-year period, with 25% of the total shares subject to the option vesting on the 1st anniversary of the grant date and the remaining 75% vesting over the subsequent three-year period in substantially equal monthly installments at a rate of 1/48th of the total shares subject to the option each month, subject to the Reporting Person's continuous service as of each vesting date.
Documents
Issuer
Arbutus Biopharma Corp
CIK 0001447028
Entity typeother
Related Parties
1- filerCIK 0001936604
Filing Metadata
- Form type
- 4
- Filed
- Mar 19, 8:00 PM ET
- Accepted
- Mar 20, 4:08 PM ET
- Size
- 6.0 KB